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Paf-acether (pat) is a phospholipid mediator of inflammation endowed with major immunoregulatory properties. The present study demonstrates 
that human thymus contains large amounts of paf, as well as paf precursors. In addition, isolated tbymic cells produced paf under ionophore stimu- 
lation. Paf from thymus exhibited the same biological and physicochemical properties as synthetic paf. The purity and molecular structure of paf 
from thymus were further characterized by reverse-phase HPLC and gas chromatography with electron-capture detection. These findings may have 
important implications since thymus microenvironment is essential in the proper development of bone marrow progenitors committed to the T 
cell lineage into ~ymo~ytes capable of emigmting to the periphery as functional T lymph~yt~. 
Platelet-activating factor-a&her; Thymus 
I. INTRODUCTION These results could be of importance for the understan- 
ding of human intrathymic T cell differentiation. 
Paf-acether (paf, 1 -~-~kyl-2-acetyl-so- 
glycero-3-phosphocholine) is a phospholipid mediator 
of infl~mation that is released from and activates a 
variety of in~ammatory cells such as platelets, 
neutrophils, eosinophils and monocytes/macrophages 
[l-3]. Recently, several effects of paf on the immune 
response have been unveiled. For example, paf 
modulates cell surface structures that play a crucial role 
in T cell function and interferes with the processes 
leading to T cell activation [4,5]. It was thus of interest 
to investigate whether paf could be synthesized in the 
whole thymus. Indeed, thymus is an anatomic~ly com- 
plex organ critical for the development of immune 
function in young mammals. It is composed of an 
epithelial stroma, thymocytes, dendritic cells, 
macrophages and connective tissue. Although a great 
deal is known about the cell types that occupy the 
thymus and their interactions, the signals involved in 
the processes of lymphocyte maturation are still to be 
elucidated 163. 
2. MATERIALS AND METHODS 
2.1. Processing of thymus tissue 
Thymus were obtained from f-year-old patients who had part of 
their thymus removed during cardiac surgery. Portions of the thymus 
were weighed, minced into small pieces and then washed in saline to 
remove blood cells. Subsequently, the minced thymus tissue was 
pulverized and homogenized in methanol at 4’C. Lipids were then ex- 
tracted using the method of Bligh and Dyer f7]. Phospholipids were 
purified by normal-phase high performance liquid chromatography 
(HPLC) and different fractions assayed for platelet-aggregating ac- 
tivity 181. 
2.2. Isolation of thymic cells 
In the present study, we demonstrate that human 
thymus contains large amount of paf and that isolated 
thymus cells produce paf under ionophore stimulation. 
Single cell suspensions were obtained by mincing a portion of the 
thymus and then pressing the fragments through a stainless teel mesh 
as described previously [9]. This poputation was shown to contain 
more than 95% CD2+ cells. Isolated thymic cells, 1 to 50 x IO6 
cells/ml, were stimulated by 2pM ionophore A23187 (IoA) 
(Calbiochem, La Jolla, CA) at 37°C in Hepes-buffer saline (HBS) 
containing 2.5 mg/ml fatty acid-free bovine serum albumin (Sigma 
Chemical Co., St. Louis, MO) [lo]. After various periods of time, 
total paf was recovered using ethanoiic extraction of both super- 
natants and cell pellets, as described [lo]. 
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Washed rabbit platelets were prepared as in Ill]. Aspirinated- 
platelets (1.6 x 10”) in Tyrode’s buffer (3OOpl) containing 2.5% 
gelatin and the ADP scavenger mixture, creatine phosphate 
(1 mM)/~reatine phosphokinase (10 U/ml) were stirred in an ag- 
gregometer (Icare, Marseille, France). Aggregating activity of the 
samples was measured over the linear portion of the calibration curve 
obtained with 5-50 pg synthetic paf (Bachem, E)ubendorf, 
Switzerland). 
This paper is fifth of a series: Immnnoregulatory functions of paf- 
acether 
2.4. Assay for 1~s~ paf and I-alkyl-2-acyl-glycerophosphocholine 
(AAGPC) 
Lyso paf was measured in samples after its chemical acetyfation in- 
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to paf as previously described [IO]. The amount of lyso paf was 
established as the difference between the quantity of paf measured 
before and after acetylation of the samples. AAGPC was measured 
after alkaline hydrolysis and acetylation as described [lo]. 
2.5. Gas chromatography with electron capture detection (GC-ECD) 
Samples obtained after HPLC separation were hydrolysed to the 
diglycerides with phospholipase C from C. welchii, followed by hep- 
tafluorobutyrate (HFB) derivatization. CC-ECD was performed us- 
ing a Girdel 30 instrument (Delsi, Suresnes, France) and an OV 1 
fused silica capillary column (0.25 mm id x 25 m long) maintained 
at 215°C. The temperature of the capillary injector was kept at 
270°C. The capillary head pressure was set at 0.4 bar with helium as 
carrier gas. For ECD, nitrogen was used as a make-up gas at a flow 
rate of 30 ml/min and the 10 mCi 63Ni detector was maintained at 
300°C [12]. 
2.6. Statistical analysis 
Means of at least 3 independent experiments were compared using 
the Student’s t-test for paired variables. 
3. RESULTS 
Lipids were extracted from thymus and subjected to 
normal phase HPLC. Paf was quantitated by bioassay 
as described in section 2. As illustrated in table 1, paf 
content in thymus ranged from 38.80 to 97.19 pmol/g 
wet wt (n = 6). The concentration of AAGPC in 
thymus was several orders of magnitude greater than 
that of lyso paf and paf. The molecular ratios of paf to 
lyso paf and to AAGPC were 1: 82 and 1: 1633, respec- 
tively. The bioactive paf material was characterized as 
1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine by the 
following biological and physicochemical criteria: (i) 
the aggregating activity found in the extract was totally 
inactivated by treatment with phospholipase A2 but not 
with lipase Ar [13]; (ii) two paf antagonists L-652,731 
(generously provided by Dr J. Chabala, Merck Sharp 
and Dohme, Rahway, NJ) and WEB-2086 (obtained 
from Boehringer, Ingelheim, FRG) inhibited submax- 
imal platelet aggregation induced by thymus and syn- 
thetic paf. Furthermore, the active fractions eluted 
from normal-phase HPLC were pooled and analysed 
using GC-ECD. As depicted in fig.1, two peaks were 
identified and assigned to 16 : 0 paf (85%) and 18 : 0 paf 
(15%). Similar results were obtained for aggregating 
samples obtained after chemical treatment of AAGPC 
or lyso paf (not shown). 
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Fig. 1. CC-ECD obtained from heptafluorobutyrate derivatives of 
paf extracted from thymus. l, O-CH3 Cl6 paf (internal standard); 2, 
16:0-paf; 3, 18:0-paf; x, unknown compounds. 
spontaneously. In the presence of 2 FM IoA, the 
amount of paf increased sharply within the first 2 min 
of stimulation, plateaued from 20 to 30 min and 
decreased thereafter. Of note, paf level at 20 min was 
null when 4 x lo6 cells/ml/tube were used but rose to 
2.5 + 0.73 pmol (mean & SE, n = 4, P < 0.01) for 1 
x lo7 cells and reached a plateau of 6.12 + 1.5 pmol 
for 4 to 10 x lo7 cells (n = 4, P < 0.01). One interpreta- 
tion of this observation is that only a minor fraction of 
the whole thymic population actively produces paf. In- 
deed, when thymic cells were enriched in non-lymphoid 
Additional experiments hown in fig.2 indicate that 
unfractionated thymic cells were able to produce paf 
Table 1 
Paf and paf precursors in human thymus 
,a , 
0 
I 
20 40 88 120 
lime (min) 
Paf (pmol) Lyso paf (nmol) AA-GPC (nmol) 
67.2 f 14.7 5.5 + 2.2 110.7 f 12.5 
Lipids were extracted from thymus and subjected to normal phase 
HPLC. Paf and paf precursors were quantitated by bioassay as 
described in section 2. The results are expressed per g wet wt 
(means k SE of tissue samples from six donors) unstimulated cells. 
Fig.2. Time course of paf production by IoA-stimulated thymocytes. 
Isolated thymic cells (40 x 106/ml) were incubated for varying 
periods of time at 37°C either in the presence (o--o) or in the 
absence (0) of 2 pM IoA. Total paf (released + cell-associated) was 
recovered using ethanolic extraction and then measured by 
aggregation of washed rabbit platelets as described in section 2. The 
mean f SE of 7 different experiments is indicated. P-values were 
* P < 0.01, ** P < 0.001 for stimulated cells as compared to 
50 
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populations (CDZnegative cells), 7.12 f 1.0 pmol paf 
was obtained for 1 x lo6 cells (n = 3). 
The material extracted from thymic cells after 
ionophore stimulation exhibited biological and 
physicochemical properties identical to those of either 
synthetic paf or paf extracted from the whole thymus 
according to the criteria described above. Reverse- 
phase HPLC and gas chromatography also indicated 
that most of the paf generated was of the hexadecyl 
species (not shown). 
4. DISCUSSION 
The present results indicate that human thymus con- 
tains large amounts of paf as well as paf precursors, 
AAGPC and lyso paf. Identification of paf was based 
on the stringent functional and biophysical criteria 
detailed above including reverse-phase HPLC and gas 
chromatography analysis. It is unlikely that circulating 
blood accounted for the amount of paf found in the 
thymus since: (i) small fragments of tissue were exten- 
sively rinsed till blanching before being homogenized in 
methanol; (ii) the amount of bioactive paf found in 
blood was 16.2 -t 4.3 pmol/g, mean + SE of samples 
from 10 individuals; (iii) isolated thymic cells produced 
paf spontaneously and the amount of paf was highly 
enhanced by the addition of IoA to the culture. Two 
specific enzymatic reactions have been documented to 
be involved in paf biosynthesis. An acetyl-CoA 
acetyltransferase that catalyzes the acetylation of inac- 
tive lyso paf into the bioactive paf whereas a CDP- 
choline cholinephosphotransferase transfers the 
phosphobase from CDP-choline to alkyl-acetyl- 
glycerol [14]. Whether the thymic paf originates from 
the de novo or the remodeling pathway remains to be 
investigated. However, it is interesting to note that 
Wykle et al. have previously reported that rat thymus 
contained acetyltransferase activity in high amounts 
11% 
At the present time, the precise cellular origin of 
thymus paf remains an open question. One possibility 
is that it originates from nonlymphoid populations 
such as dendritic cells, macrophages or epithelial cells. 
An alternative view is that thymocytes themselves can 
form paf. We favor the former interpretation since our 
results indicate that CDZnegative cells were far more 
efficient than CD2-positive cells in producing paf. This 
does not, however, eliminate the possibility that subsets 
of thymocytes could also produce paf. Clearly, addi- 
tional studies using distinct isolated and/or cloned cell 
populations will be necessary to address these issues. 
The potential significance of these findings must be 
considered in light of the role of thymus in T cell on- 
togeny along with our recent studies demonstrating that 
paf modulates T cell function. For example, we showed 
that paf inhibited T cell activation induced via the CD3 
pathway (antigen-restricted) but potentiated that induc- 
ed via the CD2 pathway (antigen-unrestricted) (Vivier 
et al., submitted). Thus, it is conceivable that paf may 
regulate the ability of thymocytes to participate in 
CD3- and CDZrestricted interactions [ 161. Regardless 
of the exact role of paf in the thymus, these data, when 
considered together, indicate a more fundamental role 
for paf than the now classical ones in allergy and in- 
flammation and point out paf as a candidate in the 
regulation of intrathymic T cell differentiation. 
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